Director/PDMR Shareholding

RNS Number : 0594H

Mediclinic International plc

02 June 2017

 

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

("Mediclinic", the "Company" or the "Group")

2 June 2017

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

Awards under the Company's Long-Term Incentive Plan

On 1 June 2017, awards over ordinary shares in Mediclinic (the "Shares") were granted to the following Directors and other persons discharging managerial responsibilities ("PDMRs") under the rules of the Company's Long-Term Incentive Plan (the "LTIP"), which was approved by shareholders in December 2015:

Name	Director/ PDMR	Number of Shares awarded under the LTIP
Danie Meintjes	Director	129,626
Jurgens Myburgh	Director	65,263
Dr Ronnie van der Merwe	PDMR	26,898
Gert Hattingh	PDMR	26,898
Dr Dirk le Roux	PDMR	21,211
Koert Pretorius	PDMR	26,691
David Hadley	PDMR	18,397
Dr Ole Wiesinger	PDMR	22,350

Nil consideration per share was paid for the grant of the awards, which are structured as conditional awards.

The vesting of an award is subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company. The awards for PDMRs will normally vest on the later of the third anniversary of grant, other than for those PDMRs who also sit on the Board of Directors of Mediclinic International PLC whose awards will vest on the later of the fifth anniversary of grant.

The following notification made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation relates to the Company's LTIP.

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Daniël Petrus Meintjes
2.	Reason for the notification
a)	Position / status	Chief Executive Officer of the Company
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Mediclinic International plc
b)	LEI	2138002S5BSBIZTD5I60
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification Code	Ordinary Shares GB00B8HX8Z88
b)	Nature of the transaction	Award over ordinary shares in Mediclinic International plc granted under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil cost 129,626
d)	Aggregated information Aggregated volume Price	129,626 ZAR0.00
e)	Date of the transaction	1 June 2017
f)	Place of the transaction	Johannesburg Stock Exchange

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Petrus Jurgens Myburgh
2.	Reason for the notification
a)	Position / status	Chief Financial Officer of the Company
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Mediclinic International plc
b)	LEI	2138002S5BSBIZTD5I60
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification Code	Ordinary Shares GB00B8HX8Z88
b)	Nature of the transaction	Award over ordinary shares in Mediclinic International plc granted under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil cost 65,263
d)	Aggregated information Aggregated volume Price	65,263 ZAR0.00
e)	Date of the transaction	1 June 2017
f)	Place of the transaction	Johannesburg Stock Exchange

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Dr Carel A van der Merwe
2.	Reason for the notification
a)	Position / status	Chief Clinical Officer of the Company
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Mediclinic International plc
b)	LEI	2138002S5BSBIZTD5I60
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification Code	Ordinary Shares GB00B8HX8Z88
b)	Nature of the transaction	Award over ordinary shares in Mediclinic International plc granted under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil cost 26,898
d)	Aggregated information Aggregated volume Price	26,898 ZAR0.00
e)	Date of the transaction	1 June 2017
f)	Place of the transaction	Johannesburg Stock Exchange

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Gert C Hattingh
2.	Reason for the notification
a)	Position / status	Chief Corporate Services Officer of the Company
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Mediclinic International plc
b)	LEI	2138002S5BSBIZTD5I60
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification Code	Ordinary Shares GB00B8HX8Z88
b)	Nature of the transaction	Award over ordinary shares in Mediclinic International plc granted under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil cost 26,898
d)	Aggregated information Aggregated volume Price	26,898 ZAR0.00
e)	Date of the transaction	1 June 2017
f)	Place of the transaction	Johannesburg Stock Exchange

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Dr Dirk Cornelius le Roux
2.	Reason for the notification
a)	Position / status	Chief Information Officer of the Company
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Mediclinic International plc
b)	LEI	2138002S5BSBIZTD5I60
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification Code	Ordinary Shares GB00B8HX8Z88
b)	Nature of the transaction	Award over ordinary shares in Mediclinic International plc granted under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil cost 21,211
d)	Aggregated information Aggregated volume Price	21,211 ZAR0.00
e)	Date of the transaction	1 June 2017
f)	Place of the transaction	Johannesburg Stock Exchange

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Koert Hendrik S Pretorius
2.	Reason for the notification
a)	Position / status	Chief Executive Officer - Mediclinic Southern Africa
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Mediclinic International plc
b)	LEI	2138002S5BSBIZTD5I60
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification Code	Ordinary Shares GB00B8HX8Z88
b)	Nature of the transaction	Award over ordinary shares in Mediclinic International plc granted under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil cost 26,691
d)	Aggregated information Aggregated volume Price	26,691 ZAR0.00
e)	Date of the transaction	1 June 2017
f)	Place of the transaction	Johannesburg Stock Exchange

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	David J Hadley
2.	Reason for the notification
a)	Position / status	Chief Executive Officer - Mediclinic Middle East
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Mediclinic International plc
b)	LEI	2138002S5BSBIZTD5I60
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification Code	Ordinary Shares GB00B8HX8Z88
b)	Nature of the transaction	Award over ordinary shares in Mediclinic International plc granted under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil cost 18,397
d)	Aggregated information Aggregated volume Price	18,397 ZAR0.00
e)	Date of the transaction	1 June 2017
f)	Place of the transaction	Johannesburg Stock Exchange

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Dr Thorsten Ole Wiesinger
2.	Reason for the notification
a)	Position / status	Chief Executive Officer - Hirslanden
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Mediclinic International plc
b)	LEI	2138002S5BSBIZTD5I60
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification Code	Ordinary Shares GB00B8HX8Z88
b)	Nature of the transaction	Award over ordinary shares in Mediclinic International plc granted under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil cost 22,350
d)	Aggregated information Aggregated volume Price	22,350 ZAR0.00
e)	Date of the transaction	1 June 2017
f)	Place of the transaction	Johannesburg Stock Exchange

About Mediclinic International plc

Mediclinic is an international private healthcare group with operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based private healthcare group.

Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 000 inpatient beds in total; Hirslanden operates 16 private acute care facilities and 4 clinics in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East operates 6 hospitals and 31 clinics with more than 700 inpatient beds in the United Arab Emirates.

During February 2016, the combination of the Company (previously named Al Noor Hospitals Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, and Mediclinic International Limited was completed. Mediclinic International Limited was a South African based international private healthcare group founded in 1983 and listed on the JSE, the South African stock exchange, since 1986, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates (mainly in Dubai). The combination resulted in the renaming of the enlarged group to Mediclinic International plc.

Mediclinic has a primary listing on the Main Market of the LSE, with secondary listings on the JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Capita Company Secretarial Services Limited

Victoria Dalby

[phone]

Investor Relations, Mediclinic International plc

James Arnold, Head of Investor Relations

[e-mail]

[phone]

Media queries

FTI Consulting

Brett Pollard/Debbie Scott (UK)

[phone]

Frank Ford (South Africa)

[phone]

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

 

END

 

 

DSHBSGDLLDGBGRD